Back60 Degrees Pharmaceuticals- Warrants (16/05/2028) Overview
60 Degrees Pharmaceuticals Inc - Warrants (16/05/2028)

60 Degrees Pharmaceuticals- Warrants (16/05/2028) Return on Equity

Valuation check: SXTPW's ROE is -320.9%, below the sector sector average of -5.84%.

Get informed when a big investor buys or sells

+ Follow

ROE

-320.90%

Return on Equity

-320.90%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

60 Degrees Pharmaceuticals- Warrants (16/05/2028) (SXTPW) FAQ

60 Degrees Pharmaceuticals- Warrants (16/05/2028) (SXTPW) currently reports a ROE of -320.9%. That is below the sector sector average of -5.84%. Use the charts on this page to explore 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s ROE history and peer comparisons.

60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s ROE of -320.9% is lower than the its sector sector average of -5.84%. That is roughly 5390.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s current -320.9% should be judged against industry norms (sector average: -5.84%) and against SXTPW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -320.9%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.84%. From there, open related valuation or income-statement pages for 60 Degrees Pharmaceuticals- Warrants (16/05/2028), and consider following SXTPW for alerts when major investors trade the stock.